Primary completion· ClinicalTrials.gov
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
RBS2418 History and Updates
10 events · 2022 – present
Synced daily from openFDA and ClinicalTrials.gov. Last sync: .
0
FDA Approvals
0
Label Revisions
10
Trial Milestones
0
Pivotal Publications
Source: openFDA, ClinicalTrials.gov via AACT, PubMed · Hipa.ai, 2026-05-19Download chart as PNG
This page tracks every FDA action, clinical trial milestone, and major publication for RBS2418 since 2022, drawn from openFDA, ClinicalTrials.gov, and PubMed.
Upcoming & expected milestones
Primary completion· ClinicalTrials.gov
Evaluation of RBS2418 in Combination With Tremelimumab Plus Durvalumab in Participants With Advanced Unresectable Hepatocellular Carcinoma
Primary completion· ClinicalTrials.gov
Evaluation of RBS2418 in Patients With Advanced, Metastatic, and Progressive Colorectal Cancer
Past events
2026
Trial started· ClinicalTrials.gov
Evaluation of RBS2418 in Combination With Tremelimumab Plus Durvalumab in Participants With Advanced Unresectable Hepatocellular Carcinoma
2025
Trial registered· ClinicalTrials.gov
Evaluation of RBS2418 in Combination With Tremelimumab Plus Durvalumab in Participants With Advanced Unresectable Hepatocellular Carcinoma
Trial registered· ClinicalTrials.gov
Evaluation of RBS2418 in Patients With Advanced, Metastatic, and Progressive Colorectal Cancer
Trial started· ClinicalTrials.gov
Evaluation of RBS2418 in Patients With Advanced, Metastatic, and Progressive Colorectal Cancer
2023
Trial registered· ClinicalTrials.gov
Expanded Access RBS2418 Treatment
2022
Trial started· ClinicalTrials.gov
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
Trial registered· ClinicalTrials.gov
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
Sources
FDA approvals, label revisions, and recalls come from the public openFDA APIs (Drugs@FDA, Drug Label, Drug Enforcement). Drug-safety communications come from the FDA RSS feed. Trial milestones come from ClinicalTrials.gov via the AACT pg dump. Pivotal-publication events come from PubMed, filtered to high-impact journals linked to a Phase 3 trial in our inventory.